GlassScriptPhysician profile
Suzanne Spivey Brown
NPI 1336137124
$19,603.40
in general payments reported to CMS, 2019-2025
35 companies · $4,684 in 2025
The $4,684 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,304 · 2022: $3,288 · 2023: $5,803 · 2024: $3,524 · 2025: $4,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $1,575 · Education: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,843.56 |
| Consulting Fee | $1,575.00 |
| Education | $592.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,707.24 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $2,649.11 | 2021-2024 | Jublia, Cabtreo |
| Janssen Biotech, INC. | $1,895.87 | 2021-2025 | Tremfya, Stelara, Remicade |
| Medimetriks Pharmaceuticals, INC. | $1,835.94 | 2022-2025 | Clindacin Etz, Neuac, Neo-Synalar |
| Genzyme Corporation | $1,235.04 | 2021-2025 | |
| Pfizer INC. | $1,109.70 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $1,055.16 | 2021-2025 | Ilumya, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $938.27 | 2022-2025 | Sotyktu |
| Botanix Sb INC | $707.02 | 2025 | Sofdra |
| Ucb, INC. | $681.40 | 2023-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $650.88 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $628.09 | 2021-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $593.14 | 2021-2025 | |
| Galderma Laboratories, L.P. | $426.64 | 2021-2025 | Aklief, Epsolay, Oracea |
| Incyte Corporation | $412.74 | 2021-2025 | Opzelura, Opzelura |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $304.36 | 2024-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $245.65 | 2023-2025 | Zoryve |
| Amgen INC. | $222.40 | 2021-2025 | Otezla |
| Mayne Pharma Commercial LLC | $198.58 | 2021-2025 | |
| Dermavant Sciences, INC. | $184.91 | 2024 | Vtama |
| Almirall LLC | $167.68 | 2021-2023 | Klisyri |
| Journey Medical Corporation | $120.64 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $110.90 | 2022 | |
| Tela Bio, INC. | $83.35 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Biofrontera INC. | $83.27 | 2021-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Convatec INC. | $72.71 | 2025 | |
| Vyne Pharmaceuticals INC. | $71.08 | 2021 | |
| Epi Health, LLC | $63.94 | 2021-2022 | |
| Genentech USA, INC. | $25.00 | 2021 | |
| Organon LLC | $24.66 | 2025 | Vtama |
| Ani Pharmaceuticals, INC. | $23.30 | 2023 | Oxistat |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.72 | 2024 | Spevigo |
| Organogenesis INC. | $21.54 | 2025 | Nushield |
| Integra Lifesciences Corporation | $17.30 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.